Press Releases & News

news

Inato improves platform to boost trial access and inclusion

By leveraging the Inato platform, research sites can reuse data from one trial to another.

November 2022
news

Inato Drives Improvements to Access and Inclusion in Global Clinical Trials with Latest Platform Enhancements

Company also grew global community site adoption of the Inato platform by more than 120% YOY

November 2022
news

Startup Inato built technology to reach the 90% of sites ignored in clinical research. Here's how it works

Inato CEO Kourosh Davarpanah shared the company's growth over 2022 and explains how their platform empowers community-based investigators to bring the right trials to their patients.

November 2022
news

Inato to Host Roundtables on Improving Clinical Trials Through New Approaches to Site Selection

Inato hosts two discussions around challenges in accessing patients and innovative approaches to overcoming those barriers and partnering with community-based sites at the Clinical Operations Strategy Meeting on May 18 in Cambridge, Massachusetts

May 2022
news

Health Tech: Kourosh Davarpanah On How Inato’s Technology Can Make An Important Impact On Our Overall Wellness

In an interview with Authority Magazine for their series on "Technology Making An Important Positive Social Impact" Inato CEO, Kourosh Davarpanah, shares the motivation behind starting Inato and the positive impact our technology can have on society.

May 2022
news

Clinical Trials and the Data Diversity Problem

Inato CSO, Liz Beatty, describes the detrimental effect of underrepresenting minority communities in clinical trials.

May 2022
news

A path toward clinical trial diversity

CSO, Liz Beatty, describes how the lack of diversity across clinical trials harms trial efficacy, data, and costs in op-ed.

May 2022
news

California Business Journal Exclusive: The Lack Of Diversity In Clinical Trials Is Staggering

The lack of diversity in clinical trials is staggering. Liz Beatty, who has spent nearly two decades as Director of Clinical Trials at Bristol-Myers Squibb, is changing that as Inato’s Chief Strategic Officer.

March 2022
news

Inato appoints CSO Liz Beatty to Board of Directors

Beatty brings decades of experience in leadership and clinical trial management

March 2022
news

Diverse site staff better fits inclusive patient population: Inato

Liz Beatty from Inato discusses how patient experience can be enhanced when the clinical trial team shares a background with the subjects.

March 2022
news

Clinical Trial Marketplace Inato Sees Record Growth in 2021

Inato broadens clinical trial access by offering pharmaceutical companies direct access to community-based research sites and the patients they serve

February 2022
news

Raising Representation in Clinical Trials: An Interview with Liz Beatty, Inato

Driven by COVID’s disparate effect on certain ethnicities, the pandemic exacerbated the issue of certain patient populations being unable to access suitable trials. Proventa spoke to Liz Beatty, Chief Strategy Officer at Inato, about how they believe this issue can be rectified. 

August 2021
news

Sanofi, Merck KGaA, Darmstadt, Germany, and More Than 500 Sites Join Inato in Making Clinical Research More Inclusive and Efficient

The Inato Marketplace is Reinventing the Collaboration Model Between Clinical Trial Sponsors and Sites

January 2021
news

Clinical Trial Diversity: It’s Time to Stop Talking the Talk and Start Walking the Walk

"The lack of diversity in clinical trials is a disturbing, ethical problem that’s persisted for decades," said Liz Beatty in an article this week on Applied Clinical Trials Magazine where she discusses that it is time to stop talking the talk and start walking the walk when it comes to clinical trial diversity.

January 2021
news

Trendspotting: Decentralized Trials, AI, Real-World Data in 2021

Clinical Research News published an article last week on some of the top trends to watch out for in clinical trials in 2021.

January 2021
news

Looking back, thinking ahead: industry leaders talk trends

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

December 2020
news

The Future of Clinical Trials will Require a Focus on the Long Tail

Inato CEO, Kourosh Davarpanah, discusses the clinical trial landscape and why the future of clinical trials will require a focus on the long tail.

December 2020
news

Inato Shares Key Company Milestones

Inato Announces the Participation of Over 300 Clinical Trial Research Sites in its Global Marketplace

September 2020
news

Inato: insightful data can boost clinical trial diversity

A leader from the clinical research technology firm talks about the importance of a diverse patient population and ways to hit the target.

August 2020
news

Clinical Trial Diversity Isn’t Just a Moral Issue–It’s a Scientific Imperative

Inato's Liz Beatty pens an op-ed in Xconomy on the pressing need for clinical trial diversity.

July 2020
news

How Clinical Trial Research Sites Can Gain Access to a More Level Playing Field

To overcome sponsor-related challenges and work to successfully secure more trials, there are tactical steps CROs can take.

July 2020
news

SCRS Welcomes Inato to the Global Impact Partner Program

Inato Joins SCRS as a Global Impact Partner

June 2020
news

Why the Clinical Trial Industry Needs Dynamic and Inclusive Marketplaces

By connecting supply with demand and eventually facilitating a financial transaction, marketplaces provide an online platform for supply and demand to efficiently find one another and transact seamlessly.

March 2020
news

Inato raises $14M to unlock trial site potential

Inato raises $14 million series A round to “unlock the potential of the many unengaged research sites.”

February 2020
news

Inato Raises $14M Series A

Inato Raises $14 Million in Series A Funding from Obvious Ventures, Cathay Innovation, Serena and Fly Ventures

February 2020
news

The Sanofi-partnered startup finding clinical trials for the 90%

Inato announced a $14 million Series A round led by Obvious Ventures and Cathay Innovation, and joined by Serena and Fly Ventures.

February 2020
news

Appointment: Liz Beatty CSO

Inato Appoints Pharmaceutical Industry Veteran Liz Beatty as Chief Strategy Officer

April 2019

Stay connected

Keep up to date on our latest trials, news, or upcoming events by subscribing to our newsletter.